Indivior Pharmaceuticals Inc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 346,000 | 562,000 | 695,000 | 884,000 | 872,000 |
| Depreciation Amortization | 32,000 | 26,000 | 28,000 | 27,000 | 25,000 |
| Accounts receivable | -9,000 | 3,000 | 110,000 | -32,000 | -105,000 |
| Accounts payable and accrued liabilities | 145,000 | -50,000 | 63,000 | -3,000 | 10,000 |
| Other Working Capital | 127,000 | -52,000 | 171,000 | -37,000 | -101,000 |
| Other Operating Activity | -321,000 | -49,000 | -276,000 | 27,000 | 14,000 |
| Operating Cash Flow | $320,000 | $440,000 | $791,000 | $866,000 | $715,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -27,000 | N/A | -3,000 | -3,000 | -4,000 |
| Purchase Sale Intangibles | -4,000 | -26,000 | N/A | N/A | -21,000 |
| Other Investing Activity | -4,000 | -26,000 | 0 | 0 | -21,000 |
| Investing Cash Flow | $-31,000 | $-26,000 | $-3,000 | $-3,000 | $-25,000 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -112,000 | 9,000 | N/A | N/A | N/A |
| Dividend Paid | -23,000 | -500,000 | -239,000 | N/A | N/A |
| Other Financing Activity | -9,000 | 401,000 | -567,000 | -845,000 | -697,000 |
| Financing Cash Flow | $-144,000 | $-90,000 | $-806,000 | $-845,000 | $-697,000 |
| Exchange Rate Effect | -9,000 | 0 | N/A | N/A | N/A |
| Beginning Cash Position | 331,000 | 7,000 | 25,000 | 7,000 | 14,000 |
| End Cash Position | 467,000 | 331,000 | 7,000 | 25,000 | 7,000 |
| Net Cash Flow | $136,000 | $324,000 | $-18,000 | $18,000 | $-7,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 320,000 | 440,000 | 791,000 | 866,000 | 715,000 |
| Capital Expenditure | -27,000 | 0 | -3,000 | -3,000 | -4,000 |
| Free Cash Flow | 293,000 | 440,000 | 788,000 | 863,000 | 711,000 |